SOCS1 is associated with clinical progression and acts as an oncogenic role in triple-negative breast cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SOCS1 is associated with clinical progression and acts as an oncogenic role in triple-negative breast cancer
Authors
Keywords
-
Journal
IUBMB LIFE
Volume 70, Issue 4, Pages 320-327
Publisher
Wiley
Online
2018-03-12
DOI
10.1002/iub.1728
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Triple negative breast cancer in Asia: An insider’s view
- (2018) Chao Wang et al. CANCER TREATMENT REVIEWS
- Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort
- (2017) Darius Juskevicius et al. Journal of Hematology & Oncology
- Breast cancer
- (2017) Nadia Harbeck et al. LANCET
- Emerging Therapeutic Strategies in Breast Cancer
- (2017) Kayla Cox et al. SOUTHERN MEDICAL JOURNAL
- Dysregulation of SOCS-Mediated Negative Feedback of Cytokine Signaling in Carcinogenesis and Its Significance in Cancer Treatment
- (2017) Mengmeng Jiang et al. Frontiers in Immunology
- Practical Approach to Triple-Negative Breast Cancer
- (2017) Vijayakrishna K. Gadi et al. Journal of Oncology Practice
- Abnormal repression of SHP-1, SHP-2 and SOCS-1 transcription sustains the activation of the JAK/STAT3 pathway and the progression of the disease in multiple myeloma
- (2017) Asma Beldi-Ferchiou et al. PLoS One
- Epigenetic profiling of gallbladder cancer and gall stone diseases: Evaluation of role of tumour associated genes
- (2016) Tekcham Dinesh Singh et al. GENE
- Suppressor of cytokine signaling 1-dependent regulation of the expression and oncogenic functions of p21CIP1/WAF1 in the liver
- (2016) M Yeganeh et al. ONCOGENE
- Suppressor of cytokine signaling 1 gene mutation status as a prognostic biomarker in classical Hodgkin lymphoma
- (2015) Jochen K. Lennerz et al. Oncotarget
- Tumour-promoting role of SOCS1 in colorectal cancer cells
- (2015) William S. Tobelaim et al. Scientific Reports
- SOCS1 Mutation Subtypes Predict Divergent Outcomes in Diffuse Large B-Cell Lymphoma (DLBCL) Patients
- (2015) Birgit Schif et al. Oncotarget
- Lack of Prognostic Significance of SOCS-1 Expression in Colorectal Adenocarcinomas
- (2014) Talat Ayyildiz et al. Asian Pacific Journal of Cancer Prevention
- Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients
- (2014) Guanghua Li et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Regulation of miR-155 affects pancreatic cancer cell invasiveness and migration by modulating the STAT3 signaling pathway through SOCS1
- (2013) CHEN HUANG et al. ONCOLOGY REPORTS
- Overexpressed DNA-binding protein inhibitor 2 as an unfavorable prognosis factor promotes cell proliferation in nasopharyngeal carcinoma
- (2012) Zhen Liu et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- SOCS-1gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical antitumor activity against malignant pleural mesothelioma
- (2012) Kota Iwahori et al. INTERNATIONAL JOURNAL OF CANCER
- Role of SOCS1 in tumor progression and therapeutic application
- (2011) Jing Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer
- (2010) Walid Sasi et al. BMC CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search